EUVIMEDΑνακαλύψτε το EUVIMED
Open access

Predicting head and neck tumor nodule responses to TLD1433 photodynamic therapy using the image‐guided surgery probe ABY ‐029

Chanda Bhandari iD, Siddharth Soma, Maxwell Quaye, Alisher Talgatov, Gal Shafirstein, Kimberley Samkoe, Sherri McFarland, Girgis Obaid

Photochemistry and Photobiology · 2025

DOI: 10.1111/php.14083 ↗

At a glance

Journal article in Photochemistry and Photobiology, 2025. Written by Chanda Bhandari and 7 co-authors. Institution: Department of Bioengineering, University of Texas at Dallas, Richardson, Texas, USA. Major MEDLINE topics: Photochemotherapy, Head and Neck Neoplasms, Photosensitizing Agents. Cited 1 times so far (Crossref); 46 references. The full text is freely available in PubMed Central. Funded by: NIBIB NIH HHS, NCI NIH HHS, National Science Foundation.

ΠερίληψηSubjectsΒιβλιογραφικά στοιχείαCiteRelated studies

Abstract (original language)

Incomplete surgical resection in head and neck cancer can lead to locoregional recurrence in >35% of patients. Approaches such as image‐guided surgery (IGS) and post‐operative photodynamic therapy (PDT) have been proposed to reduce recurrence rates. However, the PDT doses needed to eliminate all unresected diseases are not established. This in vitro proof‐of‐concept study aims to predict head and neck tumor nodule viability in vitro following PDT with TLD1433 using the IGS probe ABY‐029. ABY‐029 is an EGFR‐specific affibody‐IRDye800CW conjugate that has undergone Phase 0 evaluation studies in head and neck cancer, among others. TLD1433 is a ruthenium‐based photosensitizer in a Phase II trial for non‐muscle invasive bladder cancer. Here, we demonstrate that decreases in fluorescence emission of ABY‐029 bound to MOC1 mouse head and neck cancer nodules in vitro can be predictive of TLD1433 PDT responses. Results show that photoactivation of TLD1433 produces reactive oxygen species (ROS) that reduce MOC1 nodule fractional viability in a manner that is inversely correlated with ABY‐029 fluorescence intensity (Pearson's r = −0.9148, R 2 = 0.8369, p < 0.0001). We hypothesize that this is due to ROS‐mediated degradation of IRDye800CW. The findings warrant further studies using head and neck cancer nodules with heterogenous PDT responses and EGFR expression levels. If successful, the future goal would be to use ABY‐029 to guide the dosimetry of intraoperative PDT of the surgical bed after IGS to eliminate all microscopic diseases, reduce recurrence rates, and prolong survival.

Subjects

MeSH terms (MEDLINE)

PhotochemotherapyHead and Neck NeoplasmsPhotosensitizing AgentsAnimalsMiceHumansCell Line, TumorSurgery, Computer-AssistedErbB Receptors

Author keywords

ABY‐029TLD1433head and neck cancerimage‐guided surgeryphotodynamic therapy

Substances

Photosensitizing AgentsErbB Receptors

Authors and institutions

  • Department of Bioengineering, University of Texas at Dallas, Richardson, Texas, USA.
  • Department of Chemistry and Biochemistry, The University of Texas at Arlington, Arlington, Texas, USA.
  • Department of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
  • Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, USA.

ORCID profiles: Chanda Bhandari

Funding

  • NIBIB NIH HHS
  • NCI NIH HHS
  • National Science Foundation
  • Cancer Prevention and Research Institute of Texas
  • NIH HHS
  • National Institutes of Health

Cite

APA

Bhandari, C., Soma, S., Quaye, M., Talgatov, A., Shafirstein, G., Samkoe, K., McFarland, S., & Obaid, G. (2025). Predicting head and neck tumor nodule responses to TLD1433 photodynamic therapy using the image‐guided surgery probe ABY ‐029. Photochemistry and Photobiology. https://doi.org/10.1111/php.14083

Vancouver

Bhandari C, Soma S, Quaye M, Talgatov A, Shafirstein G, Samkoe K, et al. Predicting head and neck tumor nodule responses to TLD1433 photodynamic therapy using the image‐guided surgery probe ABY ‐029. Photochemistry and Photobiology. 2025. doi:10.1111/php.14083

BibTeX
@article{Bhandari2025,
  author = {Bhandari, Chanda and Soma, Siddharth and Quaye, Maxwell and Talgatov, Alisher and Shafirstein, Gal and Samkoe, Kimberley and McFarland, Sherri and Obaid, Girgis},
  title = {Predicting head and neck tumor nodule responses to TLD1433 photodynamic therapy using the image‐guided surgery probe ABY ‐029},
  journal = {Photochemistry and Photobiology},
  year = {2025},
  doi = {10.1111/php.14083}
}
Start for free →